An Internet medical platform in Hangzhou has officially released a medical AI ionic compound

In recent years, health has gained widespread public attention, and practices in related fields are continuing to deepen. On May 13, an Internet medical platform officially released a medical AI ion in Hangzhou, while announcing that it has entered into an exclusive collaboration with the British BMJ Group. One Internet medical platform hopes to work with a team of Chinese experts and international leading publications to create an AI product that can touch doctors.

Shen Zhenwan, chairman of the board and chief executive officer of Xiaoyuan Internet Medical Platform, said: 'Xiaoyuan Internet Medical Platform is honored to work with the BMJ Group to inject the world's leading medical intelligence into Xiaoyuan. This collaboration will help Chinese doctors solve the long-term structural dilemma facing them: the world's leading medical research is continuing to produce, but access to these evidence is not widespread, the literature is fragmented, language barriers, pay-as-you-go barriers, and the general AI philanthropy rate is high'. Since then, Chinese doctors have been able to directly connect the world's top medical literature with lithium ions for proof-of-concept questionnaires, full text readings, online translations, and medical problems in clinical practice and research.

The BMJ Group was founded in 1840 and is affiliated with the British Medical Association. This marks a pivotal step on the path to creating low-illusion, high-proof lithium AI assistants and providing the most trusted decision-making support for Chinese doctors. Faced with the rapid development of global medical AI, China needs its own authoritative academic voice, established clinical practice practices, a system of medical AI standards that meets China's national needs and is internationally verified.

Shenzhen, Chairman of the Board and CEO of the Internet Medical Platform, said that in just over three years since its extensive focus on ChatGPT3. 5 in January 2023, AI has profoundly changed the world. At the same time, relevant departments are also continuing to drive regulatory and health development in the industry.

The introduction of journal articles into the AI-medicine platform Li-ion, an innovation we are looking forward to breaking through traditional methods of obtaining knowledge to better serve Chinese doctors. This collaboration marks the beginning of a collaboration between an Internet medical platform and top international journals. This four-tiered system, from understanding to retrieval, from training to evaluation, forms a complete circular AI loop that makes every answer traceable, verifiable and trustworthy.

The 50 members of the Steering Committee set out the evaluation standards and methodologies; hundreds of evaluating physicians, from the world's top 100 medical institutions, continue to verify and provide feedback on AI responses. But back in the medical field, 5 million Chinese doctors have not really enjoyed the benefits of AI, and most doctors still face the difficulty of obtaining high-quality medical evidence. For this collaboration, Dr.

Niels Peter Thomas, CEO of BMJ Group's publishing business, said: 'BMJ Group is committed to providing high-quality medical knowledge, promoting the development of global health care. Defining the standards of the medical AI industry that shape the governance of global medical AI. From a broader perspective, the raising of health awareness is driving the continuous improvement of relevant areas.

Today, the public has reached a consensus that it is reshaping productivity and gradually becoming the new powerhouse of modern society. Enabling model societies to 'what is accurate, reliable, safe and useful answers' and ensuring that they meet the strict standards of evidence-based medicine. We are determined and able to bring together the nation's leading academic forces to build the standard of medical AI that belongs to China, serves China, and reaches the world, to contribute to China's wisdom and China's agenda for global medical AI governance.

For the first time ever, the international leading edition of China's leading AI-ion supports the leading edition in the exclusive content collaboration between AI-ion and BMJ Group, and the content and multimedia resources published in the 70 medical journals of the BMJ Group over the past decade will be the exclusive license to provide AI-ion, lithium-ion and lithium-ion to the BMJ Group's exclusive medical platform in China. In addition, CTO Wangsheng, an Internet medical platform, unveiled the four-tiered proof-of-AI architecture of lithium ions, which is the underlying technical logic behind lithium ions, unlike other generic large models. The second layer is based on PICO-based detection and data enhancement, ensuring that every sentence output is verifiable.

The third layer is model reinforcement and mitigation. At the conference, an Internet medical platform said that lithium-ion is trying to combine top medical evidence with lithium-ion, lithium-ion medical evidence, lithium-ion AI capability with three dimensions to create a more reliable medical AI assistant, directly linked to the top evidence sources in domestic and foreign publications, to help Chinese doctors solve medical problems.